You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KSI-301

Showing 1 - 25 of 194
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • KSI-301
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)

Active, not recruiting
  • Non-proliferative Diabetic Retinopathy
  • KSI-301
  • Sham injection
  • Phoenix, Arizona
  • +46 more
Sep 22, 2022

Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • KSI-301
  • +2 more
  • Bakersfield, California
  • +45 more
Jun 2, 2022

Wet Age-related Macular Degeneration Trial in Puerto Rico, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • KSI-301
  • +2 more
  • Phoenix, Arizona
  • +65 more
Jun 2, 2022

Wet Macular Degeneration Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Terminated
  • Wet Macular Degeneration
  • KSI-301
  • +2 more
  • Phoenix, Arizona
  • +74 more
Jun 2, 2022

Diabetic Macular Edema Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • KSI-301
  • +2 more
  • Phoenix, Arizona
  • +87 more
Jun 2, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Retinal Vein Occlusion
  • KSI-301
  • +2 more
  • Phoenix, Arizona
  • +140 more
Jul 20, 2022

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Systemic Lupus Erythematosus (SLE) Trial (BRL-301)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • BRL-301
  • (no location specified)
Aug 13, 2023

Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)

Active, not recruiting
  • Cocaine Use Disorder
  • +2 more
  • Overland Park, Kansas
    Altasciences
Aug 29, 2023

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • +5 more
  • BRL-301
  • Shanghai, Shanghai, China
    Shanghai ChangZheng hospital
May 7, 2023

Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

Recruiting
  • Head Neck Cancer
  • Intratumoral Injection
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 28, 2023

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

Recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • EDIT-301
  • Oakland, California
  • +18 more
Jan 10, 2023

Parkinson Disease Trial (Gemfibrozil, Placebo)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Jun 27, 2023

Perennial Allergic Rhinitis, Rhinitis, Allergic Trial in Mississauga (Treatment A, Treatment B, Treatment C)

Completed
  • Perennial Allergic Rhinitis
  • Rhinitis, Allergic
  • Treatment A
  • +2 more
  • Mississauga, Canada
    Cliantha Research
Apr 6, 2022

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Worldwide (Camidanlumab Tesirine)

Active, not recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Camidanlumab Tesirine
  • Scottsdale, Arizona
  • +72 more
Dec 15, 2022

Retinitis Pigmentosa Trial (KIO-301)

Recruiting
  • Retinitis Pigmentosa
  • Adelaide, South Australia, Australia
    Royal Adeliade Hospital
Dec 22, 2022

Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

Not yet recruiting
  • Gastric Cancer
  • Kaohsiung, Taiwan
  • +5 more
Mar 14, 2023

COVID-19 Trial (LMN-301)

Not yet recruiting
  • COVID-19
  • LMN-301
  • (no location specified)
Sep 1, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • San Francisco, California
  • +9 more
Dec 6, 2022

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022